Neuramis Deep Lidocaine

Neuramis Deep Lidocaine is a hyaluronic acid-based dermal filler developed by Medytox. It is composed of cross-linked hyaluronic acid (20 mg/mL) and lidocaine (0.3% w/v), the latter serving as a local anesthetic to minimize pain during injection. The product is manufactured using Medytox's proprietary S.H.A.P.E. (Stabilized Hyaluronic Acid & Purification Enhancement) Technology, which involves a two-step cross-linking and enhanced purification process to ensure high biocompatibility and minimal residual BDDE (less than 0.4 ppm). It is primarily indicated for the correction of moderate-to-severe facial wrinkles and folds, such as nasolabial folds, and has been evaluated in Phase 3 clinical trials in China.

Brand names

Neuramis Deep Lidocaine

Other names

Neuramis Deep with Lidocaine